NCT02021695
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Hamad Medical Corporation Doha, Qatar
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
8,024 public trials
710 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT01935466
- Conditions
- Bladder Cancer, Diabetes Mellitus, Diabetes Mellitus, Type 2, +15 more
- Locations
-
- Deptt of Endocrinology Chandigarh, India
NCT05177172
- Conditions
- Body Weight, Choroid Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
- Locations
-
- Lund University, Food Technology, Engineering and Nutrition Lund, Sweden
NCT04386187
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- University of California, San Diego San Diego, California, United States
NCT03770052
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
- Pusan National University Hospital Busan, South Korea
Completed
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
NCT03882970
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Arkansas Clinical Research Little Rock, Arkansas, United States
- Valley Research Fresno, California, United States
- National Research Institute Huntington Park, California, United States
- National Research Institute Los Angeles, California, United States
Completed
Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus
NCT03829891
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Chang'an Hospital Xi'an, China,Shanxi, China
- Shaanxi Aerospace Hospital Xi'an, China,Shanxi, China
NCT02801448
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Type 2, +4 more
- Locations
-
Not specified
NCT03353350
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Investigational Site Number 8400004 Birmingham, Alabama, United States
- Investigational Site Number 8400005 Glendale, Arizona, United States
- Investigational Site Number 8400003 Canoga Park, California, United States
- Investigational Site Number 8400007 Chula Vista, California, United States
NCT03922750
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novo Nordisk Investigational Site Walnut Creek, California, United States
- Novo Nordisk Investigational Site Roswell, Georgia, United States
- Novo Nordisk Investigational Site Idaho Falls, Idaho, United States
- Novo Nordisk Investigational Site Las Vegas, Nevada, United States